| Ytd | -86.50% | |
| 1y | -94.28% |
| Open | 0.16 | Prev Close | 0.17 | Low | 0.15 | High | 0.16 | Mkt Cap | 3.05M |
| Vol | 2.75M | Avg Vol | 5.98M | EPS | -4.17 | P/E | N/A | Forward P/E | -1.57 |
| Beta | 0.57 | Short Ratio | 0.88 | Inst. Own | 2.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.19 | 200-d Avg | 0.86 | 1yr Est | 6.25 |
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ("Calidi" or the "Company"), a bi
Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or "the Company"), a biotechnolog